Literature DB >> 25275657

Changes in causes of death among persons with AIDS: San Francisco, California, 1996-2011.

Sandra K Schwarcz1, Annie Vu, Ling Chin Hsu, Nancy A Hessol.   

Abstract

The increased life expectancy among HIV-infected persons treated with combination antiretroviral therapy (ART), risk behaviors, and co-morbidities associated with ART place HIV-infected persons at risk for non-HIV-related causes of death. We used the San Francisco HIV/AIDS registry to identify deaths that occurred from January 1996 through December 2011. Temporal trends in AIDS- and non-AIDS-related mortality rates, the proportion of underlying and contributory causes of death, and the ratio of observed deaths in the study population to expected number of deaths among California men aged 20-79 (standardized mortality ratio [SMR]) of underlying causes of death were examined. A total of 5338 deaths were identified. The annual AIDS-related death rate (per 100 deaths) declined from 10.8 in 1996 to 0.9 in 2011 (p<0.0001), while the annual death rate from non-AIDS-related causes declined from 2.1 in 1996 to 0.9 in 2011 (p<0.0001). The proportion of deaths due to all types of heart disease combined, all non-AIDS cancers combined, mental disorders resulting from substance abuse, drug overdose, suicide and chronic obstructive pulmonary disease increased significantly over time. The SMRs for liver diseased decreased significantly over time but remained elevated. Our data highlight the importance of age-related causes of death as well as deaths from causes that are, at least in part, preventable.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25275657     DOI: 10.1089/apc.2014.0079

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  26 in total

Review 1.  Recent Insights Into Cardiovascular Disease (CVD) Risk Among HIV-Infected Adults.

Authors:  Robert C Kaplan; David B Hanna; Jorge R Kizer
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

2.  Screening for Chronic Obstructive Pulmonary Disease (COPD) in an Urban HIV Clinic: A Pilot Study.

Authors:  Daniel K Shirley; Robert J Kaner; Marshall J Glesby
Journal:  AIDS Patient Care STDS       Date:  2015-02-27       Impact factor: 5.078

3.  Correlates of viral suppression among HIV-infected men who have sex with men and transgender women in Lima, Peru.

Authors:  Katherine M Rich; Javier Valencia Huamaní; Sara N Kiani; Robinson Cabello; Paul Elish; Jorge Florez Arce; Lia N Pizzicato; Jaime Soria; Jeffrey A Wickersham; Jorge Sanchez; Frederick L Altice
Journal:  AIDS Care       Date:  2018-05-30

4.  Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States.

Authors:  Bryan Hartzler; Julia C Dombrowski; Heidi M Crane; Joseph J Eron; Elvin H Geng; W Christopher Mathews; Kenneth H Mayer; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Benigno Rodriguez; Dennis M Donovan
Journal:  AIDS Behav       Date:  2017-04

5.  Markers of chronic obstructive pulmonary disease are associated with mortality in people living with HIV.

Authors:  Matthew Triplette; Amy Justice; Engi F Attia; Janet Tate; Sheldon T Brown; Matthew Bidwell Goetz; Joon W Kim; Maria C Rodriguez-Barradas; Guy W Soo Hoo; Cherry Wongtrakool; Kathleen Akgün; Kristina Crothers
Journal:  AIDS       Date:  2018-02-20       Impact factor: 4.177

Review 6.  Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk?

Authors:  Shima Shahbaz; Marcella Manicardi; Giovanni Guaraldi; Paolo Raggi
Journal:  World J Cardiol       Date:  2015-10-26

7.  Deaths Due to Screenable Cancers Among People Living With HIV Infection, Florida, 2000-2014.

Authors:  Mary Jo Trepka; Rehab Auf; Kristopher P Fennie; Diana M Sheehan; Lorene M Maddox; Theophile Niyonsenga
Journal:  Am J Prev Med       Date:  2017-07-24       Impact factor: 5.043

8.  Sexual Orientation and All-Cause Mortality Among US Adults Aged 18 to 59 Years, 2001-2011.

Authors:  Susan D Cochran; Charlotte Björkenstam; Vickie M Mays
Journal:  Am J Public Health       Date:  2016-03-17       Impact factor: 9.308

9.  Use of rosuvastatin in HIV-associated chronic obstructive pulmonary disease.

Authors:  Alison Morris; Meghan Fitzpatrick; Marnie Bertolet; Shulin Qin; Lawrence Kingsley; Nicolas Leo; Cathy Kessinger; Heather Michael; Deborah Mcmahon; Renee Weinman; Stephen Stone; Joseph K Leader; Eric Kleerup; Laurence Huang; Stephen R Wisniewski
Journal:  AIDS       Date:  2017-02-20       Impact factor: 4.177

10.  Trends in Cardiovascular Disease Mortality Among Persons With HIV in New York City, 2001-2012.

Authors:  David B Hanna; Chitra Ramaswamy; Robert C Kaplan; Jorge R Kizer; Kathryn Anastos; Demetre Daskalakis; Regina Zimmerman; Sarah L Braunstein
Journal:  Clin Infect Dis       Date:  2016-07-20       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.